about_us_bannerabout-banner-m

Advancing Critical Care, Worldwide

Delivering trusted, life‑saving medicines and solutions to patients when they need them most.

About Us

Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL), is a global leader in inhaled anesthetics and a trusted provider of hospital generics. Our portfolio supports critical care needs across healthcare systems worldwide, ensuring patients receive the medicines they rely on during life‑defining moments.

Rooted in our purpose of saving and improving lives, PCC is committed to delivering high‑quality, dependable, and clinically important critical care solutions. Our products reach patients and healthcare professionals across the USA, Europe, and more than 100 countries, reflecting our deep responsibility for global health.

Every decision we make is anchored in trust, patient safety, and uncompromising quality. By empowering clinicians with reliable treatments and partnering with healthcare systems across continents, we strive to advance critical care and create sustainable, long‑term value for patients, providers, and stakeholders alike.

Our portfolio spans

  • inheled-hhinheled-hh-h

    Inhaled Anesthesia (Human Health)

  • Inhaled Anesthesiainheled-hh-h

    Inhaled Anesthesia (Animal Health)

  • Generic Injectablesgeneric-injectables-h

    Generic Injectables

  • Specialty  chemicalsspeciality-chemicals-h

    Specialty Chemicals

  • Pediatrics & Neonatespediatrics-h

    Pediatrics & Neonates

  • Injectable Paininjectable-pain-h

    Injectable Pain

  • 3 64 4

    Intrathecal

about_us_purpose
about_us_mission

Saving and Improving Patients' Lives

To deliver critical care solutions for patients and healthcare providers across the globe, while achieving sustainable and profitable growth for all the stakeholders.

gyan-mudra

The Gyan Mudra

The Gesture of Knowledge

Harmonising with each other, they aspire to form a circle of perfection, peace and happiness, important elements in Zen and in ancient Indian disciplines. In our brand mark the four vertical fingers of the Gyan Mudra represent our core values of Knowledge, Action, Care and Impact.

Our Values

The core values of Piramal Pharma Limited and Piramal Critical Care are an integral piece of our guiding philosophy. Values are what connect and divide us as human beings. They determine how we engage with others, what we value, what we love, and what we deem worth fighting for. Therefore, living by our values is not just important but imperative.

knowledgeknowledge-h

Knowledge

Expertise

We strive for a deeper understanding of our domain.

Innovation

We aspire to do things creatively.

actionaction-h

Action

Entrepreneurship

We are empowered to act decisively and create value.

Integrity

We are consistent in our thought, speech, and action.

carecare-h

Care

Trusteeship

We protect and enhance the interests of our customers, community, employees, partners and shareholders.

Humility

We aspire to be the best, yet strive to be humble.

impactimpact-h

Impact

Performance

We strive to achieve market leadership in scale and profitability, wherever we compete.

Resilience

We aspire to build businesses that anticipate, adapt and endure for generations.

Our Journey

  • Our entry into inhalation anesthetics began with the acquisition of the pharmaceuticals business of ICI India Limited.
  • First international acquisition of inhalation anesthetic including Isoflurane. This led to the birth of the critical care business.
  • Acquisition of brand Haemaccel from Pharmaselect (Germany).
  • Acquisition of RxElite Inc. and Minrad Inc. (USA).
  • Acquisition of business unit AltaSelect S.r.l.
  • Acquisition of injectable anesthesia business of BSV (India).
  • Acquisition of injectable anesthesia and pain management products from Janssen (Belgium).
  • Acquisition of intrathecal spasticity and pain management drugs from Mallinckrodt (USA).  Today, the Gablofen brand is #1 in the USA market.
  • Acquired YargesaTM (Miglustat).
  • Began marketing Glycopyrrolate Injection, USP, which at the time was manufactured at our affiliate Piramal Pharma Solutions CMO facility in India.
  • Licensed Linezolid Injection from Georgetown Pharmacal.
  • Acquired distribution license for Rocuronium Bromide Injection.
  • Acquired distribution license for Succinylcholine Chloride Injection, USP, Dexmedetomidine Injection, USP and Dexmedetomidine HCl in 0.9% Sodium Chloride Injection (RTU*).
    *Ready to use.
  • The pharmaceuticals business was vertically demerged from Piramal Enterprises Limited and Piramal Pharma Limited (PPL) became an independent entity to be listed separately.
  • Acquired distribution license for Zinc Sulfate Injection, USP.
  • Piramal Pharma was listed on BSE and NSE.

2002

2005

2008

2009

2010

2016

2017

2018

2019

2020

2021

2022

Design Your Destiny

Join us and shape a future where your work strengthens patient outcomes around the world.

At Piramal Critical Care, saving and improving patients’ lives is at the heart of everything we do from advancing essential critical care solutions to creating sustainable, long‑term value for all those we serve.

We foster a culture grounded in trust, integrity, and entrepreneurship, empowering you to grow, innovate, and make a lasting impact. Here, you’ll be encouraged to take ownership, develop your expertise, and contribute to work that truly matters all while staying connected to our core values of Knowledge, Action, Care, and Impact.

career-1
career-2
career-3
career-4
career-5
career-6
career-7
career-8
career-9
career-10